GATA3 expression in breast carcinoma: Utility in triple-negative, sarcomatoid, and metastatic carcinomas

Human Pathology

Volumn 44, Issue 7, 2013, Pages 1341-1349

  Cimino Mathews, Ashley ^a   Subhawong, Andrea P ^a   Illei, Peter B ^a   Sharma, Rajni ^a   Halushka, Marc K ^a   Vang, Russell ^a   Fetting, John H ^a   Park, Ben Ho ^a   Argani, Pedram ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Breast carcinoma; GATA3; Metaplastic carcinoma; Metastatic breast carcinoma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TRANSCRIPTION FACTOR GATA 3;

ADULT; ARTICLE; BREAST CARCINOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; PROTEIN EXPRESSION; SARCOMATOID CARCINOMA; TISSUE MICROARRAY;

ADULT; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; GATA3 TRANSCRIPTION FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PHYLLODES TUMOR; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84879195676     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.11.003     Document Type: Article

References (45)

1. R. Zheng, and G.A. Blobel GATA transcription factors and cancer Genes Cancer. 1 2010 1178 1188
2. J. Chou, S. Provot, and Z. Werb GATA3 in development and cancer differentiation: cells GATA have it! J Cell Physiol 222 2010 42 49
3. M.L. Asselin-Labat, K.D. Sutherland, and H. Barker Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation Nat Cell Biol 9 2007 201 209
4. H. Kouros-Mehr, E.M. Slorach, M.D. Sternlicht, and Z. Werb GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland Cell 127 2006 1041 1055
5. H. Kouros-Mehr, J.W. Kim, S.K. Bechis, and Z. Werb GATA-3 and the regulation of the mammary luminal cell fate Curr Opin Cell Biol 20 2008 164 170
6. D. Grote, A. Souabni, M. Busslinger, and M. Bouchard Pax2/8-regulated Gata3 expression is necessary for morphogenesis and guidance of the nephric duct in the developing kidney Development 133 2006 53 61
7. C.N. Ting, M.C. Olson, K.P. Barton, and J.M. Leiden Transcription factor GATA-3 is required for development of the T-cell lineage Nature 384 1996 474 478
8. K.C. Lim, G. Lakshmanan, S.E. Crawford, Y. Gu, F. Grosveld, and J.D. Engel Gata3 loss leads to embryonic lethality due to noradrenaline deficiency of the sympathetic nervous system Nat Genet 25 2000 209 212
9. C.K. Kaufman, P. Zhou, and H.A. Pasolli GATA-3: an unexpected regulator of cell lineage determination in skin Genes Dev 17 2003 2108 2122
10. M. Yang, and D. Nonaka A study of immunohistochemical differential expression in pulmonary and mammary carcinomas Mod Pathol 23 2010 654 661
11. H. Liu, J. Shi, M.L. Wilkerson, and F. Lin Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas Am J Clin Pathol 138 2012 57 64
12. J.P. Higgins, G. Kaygusuz, and L. Wang Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray Am J Surg Pathol 31 2007 673 680
13. V. Ciocca, C. Daskalakis, R.M. Ciocca, A. Ruiz-Orrico, and J.P. Palazzo The significance of GATA3 expression in breast cancer: a 10-year follow-up study Hum Pathol 40 2009 489 495
14. A. Albergaria, J. Paredes, and B. Sousa Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours Breast Cancer Res 11 2009 R40
15. S.Y. Park, H.E. Lee, H. Li, M. Shipitsin, R. Gelman, and K. Polyak Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer Clin Cancer Res 16 2010 876 887
16. A.P. Subhawong, T. Subhawong, and H. Nassar Most basal-like breast carcinomas demonstrate the same Rb-/p16+ immunophenotype as the HPV-related poorly differentiated squamous cell carcinomas which they resemble morphologically Am J Surg Pathol 33 2009 163 175
17. L.A. Carey, C.M. Perou, and C.A. Livasy Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study JAMA 295 2006 2492 2502
18. T.O. Nielsen, F.D. Hsu, and K. Jensen Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma Clin Cancer Res 10 2004 5367 5374
19. A. Cimino-Mathews, A.P. Subhawong, and H. Elwood Neural crest transcription factor Sox10 is preferentially expressed in triple negative and metaplastic breast carcinomas Hum Pathol 2012 [Epub ahead of print]
20. I.O. Ellis, C.J. Cornelisse, and S.J. Schnitt Invasive breast carcinoma F.A. Tavassoli, P. Devilee, World Health Organization classification of tumours: tumours of the breast and female genital organs 2003 IARC Press Lyon, France 37
21. J.P. Bellow, and G. Magro Fibroepithelial tumors F.A. Tavassoli, P. Devilee, World Health Organization classification of tumours: tumours of the breast and female genital organs 2003 IARC Press Lyon, France 99 103
22. P.P. Rosen Fibroepithelial neoplasms P.P. Rosen, Rosen's breast pathology 3rd Ed. 2009 Lippincott Williams & Wilkins Philadelphia, PA 187 229
23. A. Cimino-Mathews, J. Hicks, and P.B. Illei Androgen receptor expression is usually maintained in initial surgically-resected breast cancer metastases, but often lost in terminal metastases found at autopsy Hum Pathol 43 2012 1003 1011
24. J.M. Wu, M.J. Fackler, and M.K. Halushka Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases Clin Cancer Res 14 2008 1938 1946
25. A. Cimino, M. Halushka, and P. Illei Epithelial cell adhesion molecule (EpCAM) is overexpressed in breast cancer metastases Breast Cancer Res Treat 123 2010 701 708
26. D. Voduc, M. Cheang, and T. Nielsen GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value Cancer Epidemiol Biomarkers Prev 17 2008 365 373
27. W. Yan, Q.J. Cao, R.B. Arenas, B. Bentley, and R. Shao GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition J Biol Chem 285 2010 14042 14051
28. D. Tkocz, N.T. Crawford, and N.E. Buckley BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancers Oncogene 31 2012 3667 3678
29. H. Kouros-Mehr, S.K. Bechis, and E.M. Slorach GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model Cancer Cell 13 2008 141 152
30. A.B. Dydensborg, A.A. Rose, and B.J. Wilson GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis Oncogene 28 2009 2634 2642
31. I.M. Chu, A.M. Michalowski, and M. Hoenerhoff GATA3 inhibits lysyl oxidase-mediated metastases of human basal triple-negative breast cancer cells Oncogene 31 2012 2017 2027
32. J. Usary, V. Llaca, and G. Karaca Mutation of GATA3 in human breast tumors Oncogene 23 2004 7669 7678
33. S. Banerji, K. Cibulskis, and C. Rangel-Escareno Sequence analysis of mutations and translocations across breast cancer subtypes Nature 486 2012 405 409
34. R.V. Hoch, D.A. Thompson, R.J. Baker, and R.J. Weigel GATA-3 is expressed in association with estrogen receptor in breast cancer Int J Cancer 84 1999 122 128
35. M.J. van de Vijver, Y.D. He, and L.J. van't Veer A gene-expression signature as a predictor of survival in breast cancer N Engl J Med 347 2002 1999 2009
36. C.M. Perou, T. Sorlie, and M.B. Eisen Molecular portraits of human breast tumours Nature 406 2000 747 752
37. T. Sorlie, C.M. Perou, and R. Tibshirani Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci U S A 98 2001 10869 10874
38. B.J. Wilson, and V. Giguère Meta-analysis of human cancer microarrays reveals GATA3 is integral to the estrogen receptor alpha pathway Mol Cancer 7 2008 49
39. R. Mehra, S. Varambally, and L. Ding Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis Cancer Res 65 2005 11259 11264
40. P. Parikh, J.P. Palazzo, L.J. Rose, C. Daskalakis, and R.J. Weigel GATA-3 expression as a predictor of hormone response in breast cancer J Am Coll Surg 200 2005 705 710
41. N.K. Yoon, E.L. Maresh, and D. Shen Higher levels of GATA3 predict better survival in women with breast cancer Hum Pathol 41 2010 1794 1801
42. S.H. Fang, Y. Chen, and R.J. Weigel GATA-3 as a marker of hormone response in breast cancer J Surg Res 157 2009 290 295
43. N. Tominaga, Y. Naoi, and K. Shimazu Clinicopathological analysis of GATA3-positive breast cancers with special reference to response to neoadjuvant chemotherapy Ann Oncol 23 2012 3051 3057
44. R. Bhargava, S. Beriwal, and D.J. Dabbs Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity Am J Clin Pathol 127 2007 103 113
45. G.H. Lewis, A.P. Subhawong, and H. Nassar Relationship between molecular subtype of invasive breast carcinoma and expression of gross cystic disease fluid protein 15 and mammaglobin Am J Clin Pathol 135 2011 587 591